2697.HK
2697.HK
CNE100007QR0
TH MEDICAL-B
Loading chart...

Company Profile

Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for medical imaging; and five additional product, including the TH-P series of compact percutaneous puncture surgical robots which are approved for lung and abdominal puncture, the MW150 microwave ablation device, the TH-X Cryo cryoablation robot, the TH-LS KI300 and TH-LS LU100 ex vivo organ preservation and assessment systems. The company was formerly known as True Health (Guangdong Hengqin) Medical Technology Co., Ltd. and changed its name to Guangdong True Health Medical Technology Development Co., Ltd. in October 2025. The company was incorporated in 2018 and is based in Zhuhai, China.

Related stocks

600587.SS
600587.SS • China
SHINVA MEDICAL INSTRUMENT CO LT
13.12 CNY
1.19B USD 1Y -19.8%
300633.SZ
300633.SZ • China
SONOSCAPE
19.34 CNY
1.23B USD 1Y -44.3%
300482.SZ
300482.SZ • China
WONDFO BIOTECH
16.74 CNY
1.17B USD 1Y -22%
300143.SZ
300143.SZ • China
INKON LIFE
7.95 CNY
1.16B USD 1Y -9%
600055.SS
600055.SS • China
BEIJING WANDONG MEDICAL TECHNOL
10.48 CNY
1.1B USD 1Y -41.3%
300298.SZ
300298.SZ • China
CHANGSHA SINOCARE
16.68 CNY
1.39B USD 1Y -16.4%
688198.SS
688198.SS • China
BEIJING BALANCE MEDICAL TECHNOL
69.83 CNY
1.44B USD 1Y -33.7%
300206.SZ
300206.SZ • China
EDAN
11.68 CNY
1.01B USD 1Y -4.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
-
Max Drawdown (3Y)
-
Sharpe Ratio (3Y)
-
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
ende